Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market [Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electric Neurostimulation] - Forecasts till 2019
- Report Code: IN 1003
- Publish Date: Feb 2015
The internal neuromodulation market is estimated to grow the fastest in Saudi Arabia, at a CAGR of 17.9% from 2014 to 2019; while the largest market share is held by the South African internal neuromodulation segment, which is expected to grow at a CAGR of 13.1% during the given forecast period.
The rise in the incidences and prevalence of neurological diseases, rapid growth in aging population, development of advanced neurostimulation technologies, and the increasing awareness among the key factors that are fueling the growth of the internal neuromodulation technologies market in Saudi Arabia, South Africa, and Turkey. However, the lack of skilled professionals and unfavorable reimbursement scenario are some of the key challenges faced by market players.
The emerging markets such as Saudi Arabia, South Africa, and Turkey have become attractive for companies engaged in the development and marketing of the internal neuromodulation implants. Rising neurological disorders and the governments’ initiatives to increase awareness through education campaigns are the key factors propelling the demand of the internal neuromodulation technologies in these emerging market segments.
Medtronic, Inc. (U.S.) held the leading position in the Saudi Arabia, South Africa, and Turkish internal neuromodulation market. Besides Medtronic, St. Jude Medical Inc. (U.S.) and Boston Scientific Inc. (U.S.) are among other key players contributing to the concerned market. Companies such as Aleva Neurotherapeutics SA are operative in Saudi Arabian and South African deep brain stimulation modality, while Cyberonics, Inc. (U.S.) and Dynatronics Corporation (U.S.) are operational in the vagus nerve stimulation modality in these 3 countries.
Scope of the Report
This research report categorizes the Saudi Arabia, South Africa and Turkey internal neuromodulation market into the following segments and sub-segments:
Saudi Arabia, South Africa and Turkey Internal Neuromodulation Market, by Modality:
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Neurostimulation
Saudi Arabia, South Africa and Turkey Internal Neuromodulation Market, by Application:
- Spinal Cord Stimulation
- Chronic Pain
- Failed back surgery syndrome
- Ischemic Pain
- Others
- Deep Brain Stimulation
- Parkinson's Disease
- Tremor
- Depression
- Others (including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's)
- Sacral Nerve Stimulation
- Urinary Incontinence
- Fecal Incontinence
- Vagus Nerve Stimulation
- Epilepsy
- Others
- Gastric Neurostimulation
- Gastroparesis
Table Of Contents
1 Introduction (Page No. - 9)
1.1 Objectives Of The Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology (Page No. - 11)
2.1 Integrated Ecosystem Of Internal Neurostimulation/ Neuromodulation Market
2.2 Arriving At The Neuromostimulation/Neuromodulation Market Size
2.2.1 Market Share
2.2.2 Top-Down Approach
3 Executive Summary (Page No. - 13)
4 Market Overview (Page No. - 15)
4.1 Introduction
4.2 Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market
4.3 Market Drivers And Inhibitors
5 Internal Neurostimulation/Neuromodulation Market, By Modality (Page No. - 20)
5.1 Introduction
5.2 Spinal Cord Stimulation
5.3 Deep Brain Stimulation
5.4 Sacral Nerve Stimulation
5.5 Vagus Nerve Stimulaton
5.6 Gastric Electrical Stimulation (Ges)
6 Internal Neurostimulation/Neuromodulation Market, By Application (Page No. - 33)
6.1 Introduction
6.1.1 Spinal Cord Stimulation (Scs) Market, By Application/ Geography
6.1.1.1 Spinal Cord Stimulation (Scs) Market, By Application
6.1.1.2 Spinal Cord Stimulation (Scs) Market, By Geography
6.1.2 Deep Brain Stimulation (Dbs) Market, By Application/ Geography
6.1.2.1 Deep Brain Stimulation (Dbs) Market, By Application
6.1.2.2 Deep Brain Stimulation (Dbs) Market, By Geography
6.1.3 Sacral Nerve Stimulation (Sns) Market, By Application/ Geography
6.1.3.1 Sacral Nerve Stimulation (Sns) Market, By Application
6.1.3.2 Sacral Nerve Stimulation (Sns) Market, By Geography
6.1.4 Vagus Nerve Stimulation (Vns) Market, By Application/Geography
6.1.4.1 Vagus Nerve Stimulation (Vns) Market, By Application
6.1.4.2 Vagus Nerve Stimulation (Vns) Market, By Geography
6.1.5 Gastric Electrical Stimulation (Ges) Market, By Application/ Geography
6.1.5.1 Gastric Electrical Stimulation (Ges) Market, By Application
6.1.5.2 Gastric Electrical Stimulation (Ges) Market, By Geography
7 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape (Page No. - 63)
7.1 Company Share Analysis: By Modality
7.1.1 Spinal Cord Stimulation
7.1.2 Deep Brain Stimulation
7.1.3 Sacral Nerve Stimulation
7.1.4 Vagus Nerve Stimulation
7.2 Company Presence In Internal Neurostimulation/ Neuromodulation Market
8 Internal Neurostimulation/Neuromodulation Market, By Company (Page No. - 69)
8.1 Boston Scientific Corporation (U.S.)
1.1.1. Overview
1.1.2. Key Financials:
1.1.3. Product And Service Offerings
1.1.4. Related Developments
8.2 Cerbomed Gmbh (Germany)
8.2.1 Overview
8.2.2 Key Financials
8.2.3 Product And Service Offerings
8.3 Cyberonics, Inc. (U.S.)
8.3.1 Overview
8.3.2 Key Financials
8.3.3 Product And Service Offerings
8.4 Enteromedics, Inc. (U.S.)
8.4.1 Overview
8.4.2 Key Financials
8.4.3 Product And Service Offerings
8.5 Medtronic, Inc. (U.S.)
8.5.1 Overview
8.5.2 Key Financials
8.5.3 Product And Service Offerings
8.5.4 Related Developments
8.6 St. Jude Medical (U.S.)
8.6.1 Overview
8.6.2 Key Financials
8.6.3 Product And Service Offerings
8.6.4 Related Developments
8.7 Synapse Biomedical, Inc. (U.S.)
8.7.1 Overview
8.7.2 Key Financials
8.7.3 Product And Service Offerings
8.8 Uroplasty, Inc. (U.S.)
8.8.1 Overview
8.8.2 Key Financials
8.8.3 Product And Service Offerings
9 Appendix (Page No. - 82)
9.1 Customization Options
9.1.1 Product Analysis
9.1.2 Epidemiology Data
9.1.3 Surgeons/Physicians Perception Analysis
9.1.4 Regulatory Framework
9.2 Related Reports
9.3 Introducing Rt: Real-Time Market Intelligence
9.3.1 Snapshots
List Of Tables
Table 1 Global Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market, 2012 – 2019 (Usd Million)
Table 2 Internal Neuromodulation/Neurostimulation Market, By Geography, 2012 – 2019 (Usd Thousand)
Table 3 Internal Neuromodulation/Neurostimulation Market In Saudi Arabia, South Africa, And Turkey: Drivers And Inhibitors
Table 4 Internal Neurostimulation/Neuromodulation Market In South Africa,By Modality, 2013 - 2019 (Usd Thousand)
Table 5 Internal Neurostimulation/Neuromodulation Market In Turkey,By Modality, 2012 – 2019 (Usd Thousand)
Table 6 Internal Neurostimulation/Neuromodulation Market In Saudi Arabia,By Modality, 2012 – 2019 (Usd Thousand)
Table 7 Spinal Cord Stimulation Market, By Geography, 2013–2019 (Usd Thousand)
Table 8 Deep Brain Stimulation Market, By Geography, 2012–2019 (Usd Thousand)
Table 9 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (Usd Thousand)
Table 10 Vagus Nerve Stimulation Market, By Geography, 2012–2019 (Usd Mn)
Table 11 Gastric Electrical Stimulation Masks Market, By Geography,2013–2019 (Usd Thousand)
Table 12 Spinal Cord Stimulation (Scs) Market In South Africa, By Application,2012 – 2019 (Usd Thousand)
Table 13 Spinal Cord Stimulation (Scs) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Table 14 Spinal Cord Stimulation (Scs) Market In Saudi Arabia, By Application,2012 – 2019 (Usd Thousand)
Table 15 Chronic Pain Segment In Spinal Cord Stimulation (Scs) Market,By Geography, 2012 – 2019 (Usd Thousand)
Table 16 Failed Back Surgery Syndrome Segment In Spinal Cord Stimulation (Scs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Table 17 Ischemia Segment In Spinal Cord Stimulation (Scs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Table 18 Deep Brain Stimulation (Dbs) Market In South Africa, By Application,2012 – 2019 (Usd Thousand)
Table 19 Deep Brain Stimulation (Dbs) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Table 20 Deep Brain Stimulation (Dbs) Market In Saudi Arabia, By Application,2012 – 2019 (Usd Thousand)
Table 21 Parkinson’s Disease Segment In Deep Brain Stimulation (Dbs) Market,By Geography, 2012 – 2019 (Usd Thousand)
Table 22 Tremor Segment In Deep Brain Stimulation (Dbs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Table 23 Depression Segment In Deep Brain Stimulation (Dbs) Market, By Geography, 2013 - 2019 (Usd Thousand)
Table 24 Sacral Nerve Stimulation (Sns) Market In South Africa, By Application, 2012 – 2019 (Usd Thousand)
Table 25 Sacral Nerve Stimulation (Sns) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Table 26 Sacral Nerve Stimulation (Sns) Market In Saudi Arabia, By Application, 2012 – 2019 (Usd Thousand)
Table 27 Urinary Incontinence Segment In Sacral Nerve Stimulation (Sns) Market, By Geography, 2012 – 2019 (Usd Thousand)
Table 28 Fecal Incontinence Segment In Sacral Nerve Stimulation (Sns) Market,By Geography, 2012 – 2019 (Usd Thousand)
Table 29 Vagus Nerve Stimulation (Vns) Market In South Africa, By Application, 2012 – 2019 (Usd Thousand)
Table 30 Vagus Nerve Stimulation (Vns) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Table 31 Vagus Nerve Stimulation (Vns) Market In Saudi Arabia, By Application,2012 – 2019 (Usd Thousand)
Table 32 Epilepsy Segment In Vagus Nerve Stimulation (Vns) Market, By Geography, 2012 – 2019 (Usd Thousand)
Table 33 Gastric Electrical Stimulation (Ges) Market In South Africa,By Application, 2012- 2019 (Usd Thousand)
Table 34 Gastric Electrical Stimulation (Ges) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Table 35 Gastric Electrical Stimulation (Ges) Market In Saudi Arabia,By Application, 2012 – 2019 (Usd Thousand)
Table 36 Gastroparesis Segment In Gastric Electrical Stimulation (Ges) Market,By Geography, 2012 – 2019 (Usd Thousand)
Table 37 Boston Scientific Corporation: Key Financials, By Segments,2009 – 2013 (Usd Million)
Table 38 Boston Scientific: Key Financials, By Geography, 2009 – 2012 (Usd Million)
Table 39 Cyberonics, Inc.: Key Financials, 2009 - 2013 (Usd Million)
Table 40 Medtronic, Inc. : Key Financials, By Segments, 2009 - 2013 (Usd Million)
Table 41 Medtronic, Inc. : Key Financials, 2009 - 2013 (Usd Million)
Table 42 St. Jude Medical: Key Financials, By Segments, 2011 - 2013 (Usd Million)
Table 43 St. Jude Medical: Key Financials, By Geography, 2008 - 2013 (Usd Million)
Table 44 Uroplasty, Inc. : Key Financials, By Geography, 2011 - 2013 (Usd Million)
List Of Figures
Figure 1 Neurostimulation/Neuromodulation Market In Saudi Arabia,South Africa, And Turkey: Segmentation & Coverage
Figure 2 Internal Neurostimulation/Neuromodulation Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Global Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market, 2012 – 2018 (Usd Million)
Figure 5 Internal Neuromodulation/Neurostimulation Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 6 Internal Neurostimulation/Neuromodulation Market In South Africa,By Modality, 2013–2019 (Usd Thousand)
Figure 7 Internal Neurostimulation/Neuromodulation Market In Turkey,By Modality, 2013–2019 (Usd Thousand)
Figure 8 Internal Neurostimulation/Neuromodulation Market In Turkey,By Modality, 2013–2019 (Usd Thousand)
Figure 9 Spinal Cord Stimulation Market, By Geography, 2013–2019 (Usd Thousand)
Figure 10 Deep Brain Stimulation Market, By Geography, 2013–2019 (Usd Thousand)
Figure 11 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (Usd Thousand)
Figure 12 Vagus Nerve Stimulation Market, By Geography, 2013–2019 (Usd Mn)
Figure 13 Gastric Electrical Stimulation Masks Market, By Geography,2013–2019 (Usd Thousand)
Figure 14 Spinal Cord Stimulation (Scs) Market In South Africa, By Application,2012 – 2019 (Usd Thousand)
Figure 15 Spinal Cord Stimulation (Scs) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Figure 16 Spinal Cord Stimulation (Scs) Market In Saudi Arabia, By Application,2012 – 2019 (Usd Thousand)
Figure 17 Chronic Pain Segment In Spinal Cord Stimulation (Scs) Market,By Geography, 2012 – 2019 (Usd Thousand)
Figure 18 Failed Back Surgery Syndrome Segment In Spinal Cord Stimulation (Scs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 19 Ischemia Segment In Spinal Cord Stimulation (Scs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 20 Deep Brain Stimulation (Dbs) Market In South Africa, By Application,2012 – 2019 (Usd Thousand)
Figure 21 Deep Brain Stimulation (Dbs) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Figure 22 Deep Brain Stimulation (Dbs) Market In Saudi Arabia, By Application,2012 – 2019 (Usd Thousand)
Figure 23 Parkinson’s Disease Segment In Deep Brain Stimulation (Dbs) Market,By Geography, 2012 – 2019 (Usd Thousand)
Figure 24 Tremor Segment In Deep Brain Stimulation (Dbs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 25 Depression Segment In Deep Brain Stimulation (Dbs) Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 26 Sacral Nerve Stimulation (Sns) Market In South Africa, By Application, 2012 – 2019 (Usd Thousand)
Figure 27 Sacral Nerve Stimulation (Sns) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Figure 28 Sacral Nerve Stimulation (Sns) Market In Saudi Arabia, By Application, 2012 – 2019 (Usd Thousand)
Figure 29 Urinary Incontinence Segment In Sacral Nerve Stimulation (Sns) Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 30 Fecal Incontinence Segment In Sacral Nerve Stimulation (Sns) Market,By Geography, 2012 – 2019 (Usd Thousand)
Figure 31 Vagus Nerve Stimulation (Vns) Market In South Africa, By Application, 2012 – 2019 (Usd Thousand)
Figure 32 Vagus Nerve Stimulation (Vns) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Figure 33 Vagus Nerve Stimulation (Vns) Market In Saudi Arabia, By Application,2012 – 2019 (Usd Thousand)
Figure 34 Epilepsy Segment In Vagus Nerve Stimulation (Vns) Market, By Geography, 2012 – 2019 (Usd Thousand)
Figure 35 Gastric Electrical Stimulation (Ges) Market In South Africa,By Application, 2012 – 2019 (Usd Thousand)
Figure 36 Gastric Electrical Stimulation (Ges) Market In Turkey, By Application,2012 – 2019 (Usd Thousand)
Figure 37 Gastric Electrical Stimulation (Ges) Market In Saudi Arabia, By Application, 2012 – 2019 (Usd Thousand)
Figure 38 Gastroparesis Segment In Gastric Electrical Stimulation (Ges) Market,By Geography, 2012 – 2019 (Usd Thousand)
Figure 39 South Africa : Spinal Cord Stimulation , By Company, 2014
Figure 40 Saudi Arabia : Spinal Cord Stimulation , By Company, 2014
Figure 41 Turkey : Spinal Cord Stimulation , By Company, 2014
Figure 42 South Africa : Deep Brain Stimulation , By Company, 2014
Figure 43 Saudi Arabia : Deep Brain Stimulation , By Company, 2014
Figure 44 Turkey : Deep Brain Stimulation , By Company, 2014
Figure 45 South Africa : Vagus Nerve Stimulation , By Company, 2014
Figure 46 Saudi Arabia : Vagus Nerve Stimulation , By Company, 2014
Figure 47 Turkey : Vagus Nerve Stimulation , By Company, 2014
Figure 48 Internal Neurostimulation/ Neuromodulation Market: Company Coverage, By Product, 2013
Neuromodulation treats a wide range of chronic and refractory disorders. The minimally invasive/non-invasive nature of this technique increases its adoptability, which is why it is considered as an outpatient procedure. Moreover, these therapies allow physicians to cease treatment as and when required by removing the devices.
The internal neuromodulation device market accounts for the largest share of about 87.0% in the global neurostimulation/neuromodulation market–and is projected to grow further in the near future due to its advanced technology and effective outcome across sub-segments/modalities, such as spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), and vagus nerve stimulation (VNS). Rising awareness levels with regards to early diagnosis and the use of minimally invasive procedures in treatments are also expected to spur the market growth.
It is estimated that by 2018, 2.3 billion people will be affected by at least one type of lower urinary tract symptom (LUTS), such as overactive bladder (OAB) and urinary incontinence (UI). Globally, there will be about an 18% to 19% rise in LUTS disorders, of which Africa will witness a 30% to 31% increase.
Overactive bladder (OAB) syndrome negatively impacts the daily lives of a number of people. Conventional treatments such as antimuscarinics, do not always lead to sufficient improvement and are often associated with considerable side effects that result in treatment failure. In such cases, sacral neuromodulation (SNM) and botulinum toxin intravesical injections are considered as effective alternatives.
Neurostimulation therapy is becoming an integral part of clinical armamentarium to treat a variety of lower urinary tract conditions in female urology. Its increased usage stems from patients who have exhausted all other therapeutic options for lower urinary tract disorders.
The demand for internal neurostimulation/neuromodulation devices has continued to remain robust across various regions of the Middle East, especially in Saudi Arabia, Turkey, and Africa. The growing prevalence of neurological disorders as well as the increasing incidences of lower urinary tract syndrome and cardiovascular disorders across Africa drives the internal neurostimulation/neuromodulation devices market in the Middle East.
However, a complex reimbursement structure in all regions, high cost of devices, lack of trained professionals, and the presence of alternate therapies, such as drugs and electroconvulsive therapy may hamper the market growth in the coming years.
The key players of this market in Saudi Arabia, South Africa, and Turkey are Boston Scientific Corporation (U.S.), Medtronic Inc. (U.S.), and St. Jude Medical, Inc. (U.S.), Cyberonics, Inc. (U.S.), Dynatronics Corporation (U.S.), and Aleva Neurotherapeutics SA among others.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Asian Neurostimulation/Neuromodulation devices Market The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
|
European Neurostimulation/Neuromodulation Devices Market The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market. |
May 2015 |
|
|
North America Internal Neuromodulation Devices Market The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market. |
May 2015 |
